New Drug Provides Relief for Resistant Epilepsy Patients miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the speakers for its.
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 569,600 shares, a decline of 10.1% from the August 31st total of 633,900 shares. Approximately 3.1% of the shares of the company are […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) has received an average rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued a report on the stock in […]